All In Biotech

Drug Trial Radar · NCT06785454

A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

A Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled, Crossover Study to Evaluate the Efficacy and Safety of Lorundrostat in Participants With Moderate to Severe Obstructive Sleep Apnea and Hypertension

Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Feb 28, 2025

Primary completion

Dec 17, 2025

Study completion Dec 29, 2025

Sponsor

Lead sponsor
Mineralys Therapeutics Inc.Industry
Sponsor type
Industry
First posted
Jan 21, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the study is to assess the effect of lorundrostat taken orally (po) once a day on the Apnea-Hypopnea Index (AHI) in participants with moderate to severe obstructive sleep apnea (OSA) and hypertension.

Conditions

  • Obstructive Sleep Apnea
  • Hypertension

Interventions

  • LorundrostatDrug

    Lorundrostat tablet.

  • PlaceboDrug

    Lorundrostat matching placebo tablet.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Placebo-adjusted Change From Baseline in AHI at Week 4Time frame: Baseline, Week 4

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • The University of Alabama

    Tuscaloosa, Alabama

  • Chandler Clinical Trials

    Chandler, Arizona

  • Preferred Research Partners Inc.

    Little Rock, Arkansas

  • Orange County Research Institute

    Anaheim, California

  • The Neurology Center of Southern California - Profound Research, LLC

    Carlsbad, California

  • Probe Clinical Research Corporation

    Riverside, California

  • Research Carolina Elite

    Denver, Colorado

  • Nouvelle Clinical Research

    Cutler Bay, Florida

  • Arrow Clinical Trials

    Daytona Beach, Florida

  • PharmaDev Clinical Research Institute, LLC

    Miami, Florida

  • CNS Healthcare - Orlando (Clinical Neuroscience Solutions)

    Orlando, Florida

  • NeuroTrials Research Inc

    Atlanta, Georgia

  • Centricity Research Rincon Pulmonology

    Rincon, Georgia

  • Chicago Research Center Inc

    Chicago, Illinois

  • Centennial Medical Group

    Columbia, Maryland

  • Velocity Clinical Research, Rockville

    Rockville, Maryland

  • Henry Ford Health System/Henry Ford Medical Center - Columbus

    Novi, Michigan

  • Revive Research Institute, Inc

    Southfield, Michigan

  • Healthcare Research Network

    Hazelwood, Missouri

  • Clayton Sleep Institute

    St Louis, Missouri

  • Patient First MD

    Middletown, New Jersey

  • CTI Clinical Research Center

    Cincinnati, Ohio

  • Northwest Research Center

    Portland, Oregon

  • CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis)

    Memphis, Tennessee

  • Huntsville Research Institute LLC

    Huntsville, Texas

  • Sleep Therapy Research Center

    San Antonio, Texas

  • University of Washington

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.